Based on proteomic analyses and RNA expression profiling, CLSTN1 has previously been identified as a potentially pathogenic gene in ischemic cardiomyopathy and coronary artery disease in human samples [12, 13]. This evidence concerns the gene CLSTN1 and ischemic cardiomyopathy.